Pharma-Biotech Third-Quarter 2015 Update: $6.4 Billion of Investments in Project Starts

SUGAR LAND--July 14, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Within the next three months, the Pharmaceutical-Biotech Industry is expected to launch nearly $6.4 billion worth of North American capital and maintenance (MRO) projects. An analysis by Industrial Info's Pharmaceutical Tracker - Online Database of active capital and MRO projects shows that a 68% jump in spending--from third-quarter 2014's $3.8 billion. Within this article: Details on key projects from major companies, such as Boehringer Ingelheim Vetmedica, Procter & Gamble (NYSE:PG) and Genzyme (NASDAQ:GENZ), as well as Northwestern University.